CDX-1140 Demonstrates Clinical and Biological Activity in Patients with Advanced Solid Tumors in Phase 1 Dose Escalation Study

    NEXT STORY
    Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly
    PREV STORY
    Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    WishBone Medical, Inc. and Hospital for Special Surgery (HSS) Collaborate to Develop a Novel Pediatric Total Hip Implant.

    NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global ...

    author_avatar
    NASDAQ Market News

    KINESIQ Continues Its European Breakthrough With the Institut Robert Merle d’Aubigné

    GRANBY, Quebec, April 07, 2017 (GLOBE NEWSWIRE) -- KINESIQ, the developer of the first ...

    author_avatar
    NASDAQ Market News

    ContraFect Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News